The FDA lets you extend only one patent per drug approval. Most companies leave years of exclusivity on the table […]
One Shot: How to Pick the Right Drug Patent for Maximum Drug Patent Term Extension Value Read Post »
There is a persistent gap between what Western pharmaceutical executives think they know about drug patent protection in Eurasia and
Drug Patents in Eurasia: What Every Pharma Executive Actually Needs to Know Read Post »
A Strategic Guide for Pharmaceutical IP Professionals, Formulation Scientists, and Generic Drug Developers Introduction: Why Patent Claims Decide Who Wins
Every pharmaceutical patent starts its life with a 20-year timer running from the filing date. By the time a new
Every patent portfolio in the pharmaceutical industry contains dead weight. Not metaphorically — literally. Compounds whose commercial logic evaporated years
Launching a drug without a freedom-to-operate analysis is like building a factory on land you haven’t verified you own. You
How to Win Biopharma Contracts by Entering the Deal Before Generic Entry Does Why Timing Is the Only Thing That
The Number Every Pharma Strategist Gets Wrong Ask a pharmaceutical executive how long a drug patent lasts in Asia-Pacific, and
How generic drug suppliers’ litigation histories expose supply chain risk, financial fragility, and competitive staying power — before you sign
Paragraph IV Filings: The Procurement Due Diligence Tool Most Pharma Buyers Ignore Read Post »
Get fresh news and insights, drug patent expirations & more…
